CEO GH AMEA speaks about Guardant360® CDx FDA Approval
Home » CEO GH AMEA speaks about Guardant360® CDx FDA Approval

GH AMEA on Social MediaCEO GH AMEA speaks about Guardant360® CDx FDA Approval
CEO GH AMEA speaks about Guardant360® CDx FDA Approval
CEO GH AMEA speaks about Guardant360® CDx FDA Approval
GH AMEA

Here’s a short video of GH AMEA’s CEO, Simranjit Singh, speaking about Guardant Health’s Guardant360® CDx FDA Approval.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

View full press release at this link: https://lnkd.in/gwAmpCD

Message us